Clinical Trials Directory

Trials / Unknown

UnknownNCT03017248

Low-dose Ketamine for Acute Pain in the Emergency Department

Benefit of the Association of Low Doses of Ketamine With Intravenous Morphine in the Treatment of Acute Severe Pain in Emergency Department

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Faculty of Medicine, Sousse · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine the efficacy and safety of low dose ketamine in association with IV morphine in the management of acute moderate to severe pain in emergency department. The investigators hypothesize that low dose ketamine will result in more effective pain control than morphine alone and will not be associated with an increase in adverse events.

Detailed description

Management of pain in the Emergency Department is challenging. Treatment of pain is most often accomplished by parenteral opioids analgesics. However, the use of opioids alone for pain control is often associated with inadequate analgesia and increased adverse events. Low-dose ketamine has been shown to improve pain perception and produce an opioid-sparing effect when given perioperatively. Its use in the ED may probably play a role in maximizing analgesia.

Conditions

Interventions

TypeNameDescription
DRUGKetamineketamine
DRUGPlacebos0.9% normal saline
DRUGMorphineMorphine

Timeline

Start date
2016-01-01
Primary completion
2016-06-01
Completion
2017-03-01
First posted
2017-01-11
Last updated
2017-01-31

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT03017248. Inclusion in this directory is not an endorsement.